Global Brain Glucose Metabolism Surges After DMT + Harmine — But Why?
A new preprint study has found that the combination of DMT and harmine — the active components in ayahuasca — increases overall brain glucose metabolism…
-
-
Low Doses of Psilocybin Could Make VR Therapy for Social Anxiety Feel Like a Dream
A new study explores how tiny doses of psilocybin might make virtual reality therapy for social anxiety feel like a dream — and what that could mean for the…
-
One Federal Agency Called It a Breakthrough. Another Wants It in Schedule I.
In one week, Oregon dropped its plan to double psilocybin license fees and the DEA moved to place five tryptamines in Schedule I — including a compound the…
-
Dextromethorphan’s Hidden Psyche: How a Cough Suppressant Might Be More Than Just a Cold Remedy
A cough syrup may hold the key to unlocking new psychedelic experiences — but the science is still in early stages.
-
How Psychedelics Work in Your Body: A Hidden Map of Absorption, Dose, and Mystery
Somewhere in the quiet hours of the night, a person might take a pill, sip a tea, or inhale a vapor, convinced that the substance is rewiring their mind.…
-
Psychedelics and the Mind: What the Science Reveals About Healing Trauma and Depression
A groundbreaking review of clinical trials shows psychedelics may transform treatment for PTSD and depression — but the path is complex and full of…
-
Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem
A new study reveals how psilocybin and antidepressants reshape the brain’s dynamics — and why one might be more effective than the other.
-
Publication bias in psilocybin for depression: The real effect is smaller than you think
A new study reveals that the published effect of psilocybin on depression may be exaggerated by selective reporting — and the real impact is much less…
-
DMT, Madness, and Healing: How One Drug Might Simulate Both Psychosis and Therapy
DMT could be both a window into madness and a gateway to healing—new research reveals how the same drug might trigger both.
-
A Two-Threshold Model of Psilocybin Response Explains Variability in Psychedelic-Assisted Therapy for Treatment-Resistant Depression
A groundbreaking model reveals why psilocybin works for some but not others — and what really matters for healing.
